All In Biotech

Free tool

FAERS Monitor: Aplenzin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022108 or its brand name (Aplenzin, Bupropion Hydrobromide). Reports on generic versions are filed under their own applications.

Reports

577

Serious

380

66% of reports

Hospitalization

161

Death reported

52

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache130
  • asthma117
  • therapeutic product effect incomplete89
  • anxiety87
  • gastrooesophageal reflux disease85
  • wheezing85
  • dyspnoea82
  • hypertension80
  • depression78
  • fatigue71
  • drug ineffective66
  • loss of personal independence in daily activities62
  • burning sensation58
  • fibromyalgia58
  • off label use58

Reports by year received

View as table
YearReports
200911
201022
201112
201216
20138
201410
201516
201620
201717
201820
201940
202064
202181
202279
202383
202432
202529
202617

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,582 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fibromyalgiaSignal5887.268.34,849
wheezingSignal8552.343.04,234
loss of personal independence in daily activitiesSignal6247.137.22,755
therapeutic product effect incompleteSignal8945.737.73,852
gastrooesophageal reflux diseaseSignal8538.531.73,078
asthmaSignal11737.832.14,170
burning sensationSignal5830.223.61,611
hypertensionSignal8013.811.2944
depressionSignal7812.510.2822
anxietySignal8711.19.2804
headacheSignal1307.66.5756
dyspnoeaSignal825.34.3288
fatigueSignal713.32.7117
off label useSignal582.41.949
drug ineffective661.81.525

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.